Publications by authors named "Thomas A Murray"

Claim this Profile
T
The effect of percutaneous coronary intervention after extracorporeal cardiopulmonary resuscitation on survival for out of hospital cardiac arrest: a causal inference analysis.
Laith Alhuneafat, Thomas A Murray, Nicholas J Johnson, Cindy Hsu, Brian Grunau

Resusc Plus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating viral load sampling schemes and swabbing methods for optimal surrogacy.
Allyson Mateja, Eric Chu, Thomas A Murray, Carolyn T Bramante, Carlee Moser

J Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a randomized controlled trial of a resistance exercise training to treat major depression via cerebrovascular mechanisms (RESIST Trial).
Jacob D Meyer, Seana L Smith, John M Gidley, Abigail Molina, Sydney L Churchill, Thomas A Murray

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death.
Allyson Mateja, Eric Chu, Thomas A Murray, Carolyn T Bramante, Carlee Moser

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.
Ahmad Mourad, Gregory A Grandits, Lianne K Siegel, Nicole Engen, Christina Barkauskas, Thomas A Murray

Clin Microbiol Infect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose selection criteria to identify the optimal dose based on ranked efficacy-toxicity outcomes without reliance on clinical utilities.
Sydney Porter, Anne Eaton, Thomas A Murray

Stat Methods Med Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial.
Emil Lou, Modassir S Choudhry, Timothy K Starr, Timothy D Folsom, Jason Bell, Thomas A Murray

Lancet Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).
Sofía Sábato, Susana Benet, Angela J Rogers, Thomas A Murray, Melissa Skeans, Daniel D Murray

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Design for Selecting Subgroup-Specific Optimal Biological Doses for Prespecified Subgroups.
Sydney Porter, Thomas A Murray, Anne Eaton

Stat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).
Jacob D Meyer, Shania J E Kelly, John M Gidley, Jeni E Lansing, Seana L Smith, Thomas A Murray

Trials· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.
Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, Amy B Karger, David J Odde, Thomas A Murray

Clin Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment.
Katrina M Hartman, Barkha Patel, Via Rao, Aubrey A Hagen, Hanna G Saveraid, Thomas A Murray

Open Forum Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Tomas O Jensen, Thomas A Murray, Greg A Grandits, Mamta K Jain, Birgit Grund, Daniel D Murray

Lancet Microbe· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromodulation Through Spinal Cord Stimulation Restores Ability to Voluntarily Cycle After Motor Complete Paraplegia.
Caleb Hoover, Willis Schuerger, David Balser, Patricia McCracken, Thomas A Murray

J Neurotrauma· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal timing for an accelerated interim futility analysis incorporating real world data.
Lillian M F Haine, Thomas A Murray, Joseph S Koopmeiners

Contemp Clin Trials· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
Tomas O Jensen, Greg A Grandits, Mamta K Jain, Thomas A Murray, Birgit Grund, Daniel D Murray

J Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta analysis to predict the efficacy of an approved treatment in a new indication.
Jennifer L Proper, Haitao Chu, Purvi Prajapati, Michael D Sonksen, Thomas A Murray

Res Synth Methods· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled dose-escalation design to evaluate the safety of a novel pharmacological cardiopulmonary resuscitation strategy.
Sydney Benson, Demetri Yannopoulos, Tom P Aufderheide, Thomas A Murray

Clin Trials· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian hierarchical models incorporating study-level covariates for multivariate meta-analysis of diagnostic tests without a gold standard with application to COVID-19.
Zheng Wang, Thomas A Murray, Mengli Xiao, Lifeng Lin, Demissie Alemayehu

Stat Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified interactive Q-learning for attenuating the impact of model misspecification with treatment effect heterogeneity.
Yuan Zhang, David M Vock, Megan E Patrick, Thomas A Murray

Stat Methods Med Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2.
Nandini Avula, Dustin Kakach, Christopher J Tignanelli, David M Liebovitz, Jacinda M Nicklas, Thomas A Murray

J Clin Transl Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Carolyn T Bramante, John B Buse, David M Liebovitz, Jacinda M Nicklas, Michael A Puskarich, Thomas A Murray

Lancet Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome trajectory estimation for optimal dynamic treatment regimes with repeated measures.
Yuan Zhang, David M Vock, Megan E Patrick, Lizbeth H Finestack, Thomas A Murray

J R Stat Soc Ser C Appl Stat· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial.
Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, Amy B Karger, David J Odde, Thomas A Murray

medRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up.
Carolyn T Bramante, John B Buse, David Liebovitz, Jacinda Nicklas, Michael A Puskarich, Thomas A Murray

medRxiv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis